Literature DB >> 35467709

The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Piero Ruscitti1, Onorina Berardicurti1, Ilenia Di Cola1, Claudia Di Muzio1, Elena Di Nino1, Roberto Giacomelli2, Paola Cipriani1.   

Abstract

To assess stimulator of interferon genes (STING) pathway in patients with adult-onset Still's disease (AOSD) who were complicated or not by macrophage activation syndrome (MAS), evaluating peripheral blood mononuclear cells (PBMCs), and synovial tissues. The relative mRNA expression of key molecules of the STING pathway (i.e. CGAS, NLRP4, PKDC, STING1, XRCC5, and XRCC6) and interferon (IFN)-γ was assessed in PBMCs obtained from patients with AOSD, who were complicated or not by MAS, and healthy controls (HCs). A bulky RNA sequencing was performed in synovial tissues from two patients with AOSD. Finally, the ability of heavy ferritin subunit (FeH) to induce the expression of NLRP4 was evaluated in cultured macrophages. Twenty patients with AOSD were analysed. Out of them, seven patients were complicated by MAS. Assessing mRNA relative expression in PBMCs, STING1, NLRP4, XRCC6, and IFN-γ were significantly expressed in AOSD than HCs. The mRNA relative expression of CGAS, PKDC, and XRCC5 did not differ between patients and HCs. Furthermore, NLRP4 and IFN-γ resulted to be significantly increased in patients with AOSD complicated by MAS than others. By RNA-sequencing analysis, we observed that Nlrp4 gene was significantly up-regulated in patients with AOSD. Following the stimulation with FeH, an increased expression of NLRP4 was observed in cultured macrophages. In conclusion, an increased expression of some key molecules of STING pathway characterized patients with AOSD. In addition, our results suggested that a hyper-activity of NLRP4 may be observed in patients with MAS. Furthermore, FeH increased the expression of NLRP4 in cultured macrophages.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NLRP4; STING; adult-onset Still’s disease; macrophage activation syndrome

Year:  2022        PMID: 35467709      PMCID: PMC9113323          DOI: 10.1093/cei/uxac014

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  29 in total

Review 1.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

2.  Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

Authors:  Laurence Fardet; Lionel Galicier; Olivier Lambotte; Christophe Marzac; Cedric Aumont; Doumit Chahwan; Paul Coppo; Gilles Hejblum
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

3.  Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.

Authors:  Piero Ruscitti; Carmela Rago; Luciana Breda; Paola Cipriani; Vasiliki Liakouli; Onorina Berardicurti; Francesco Carubbi; Caterina Di Battista; Alberto Verrotti; Roberto Giacomelli
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

Review 4.  A STING to inflammation and autoimmunity.

Authors:  Vijay Kumar
Journal:  J Leukoc Biol       Date:  2019-04-16       Impact factor: 4.962

Review 5.  A comprehensive review on adult onset Still's disease.

Authors:  Roberto Giacomelli; Piero Ruscitti; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2018-08-01       Impact factor: 7.094

6.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

7.  H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; G Guggino; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

8.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 9.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

10.  Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.

Authors:  Piero Ruscitti; Paola Di Benedetto; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Anna Rita Lizzi; Paola Cipriani; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.